Fluorescence in situ hybridization identifies cryptic t(16;16)(p13;q22) masked by del(16)(q22) in a case of AML-M4 Eo

Journal of Molecular Diagnostics

Volumn 6, Issue 3, 2004, Pages 271-274

  Merchant, Shakil H ^a,b   Haines, Skip ^c   Hall, Bryan ^a   Hozier, John ^a,c   Viswanatha, David S ^a,c  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b VA Medical Center   (United States)

^c TRICORE REFERENCE LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CORE BINDING FACTOR; HYBRID PROTEIN; ONCOPROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW BIOPSY; BONE MARROW CELL; CASE REPORT; CELL STRUCTURE; CHROMOSOME 16P; CHROMOSOME 16Q; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION 16; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE 46,XY; MALE; MEDICAL DECISION MAKING; MOLECULAR PROBE; POLYMERASE CHAIN REACTION; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 4344705265     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-1578(10)60521-1     Document Type: Article

References (17)

1. Brunning RD, Benett J, Matutes E, Head D. Acute myeloid leukemia with recurrent genetic abnormalities. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Edited by Jaffe ES, Harris NL, Stein H, Vardiman JW. Lyon, France, IARC Press, 2001, op 81-87
2. Le Beau MM, Larson RA, Bitter MA, Vardiman JW, Golomb HM, Rowley JD: Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia: a unique cytogenetic-clinicopathological association. N Engl J Med 1983, 309:630-636
3. Bloomfield CD, Baer MR, Wurster-Hill D: Prognostic factors for selecting curative therapy for adult acute myeloid leukemia. Leukemia 1992, 6:65-67
4. Ghaddar HM, Plumkett W, Kantarjian HM, Pierce S, Freireich EJ, Keating MJ, Estey EH: Long-term results following treatment of newly diagnosed acute myelogenous leukemia with continuous-infusion of high-dose cytosine arabinoside. Leukemia 1994, 8:1269-1274
5. Mrozek K, Prior TW, Edwards C, Marcucci G, Carroll AJ, Snyder PJ, Koduru PR, Theil KS, Pettenati MJ, Archer KJ, Caligiuri MA, Vardiman JW, Kolitz JE, Larson RA, Bloomfield CD: Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a cancer and leukemia group B study. J Clin Oncol 2001, 19:2482-2492
6. Ritter M, Thiede C, Schakel U, Schmidt M, Alpen B, Pascheberg U, Mohr B, Ehninger G, Neubauer A: Underestimation of inversion (16) in acute myeloid leukemia using standard cytogenetics as compared with polymerase chain reaction results of a prospective investigation. Br J Hematol 1997, 98:969-972
7. Rowe D, Cotterill SJ, Ross FM, Bunyan DJ, Vickers SJ, Bryon J, McMullan DJ, Griffiths MJ, Reilly JT, Vandenberghe EA, Wilson G, Watmore AE, Bown NP: Cytogenetically cryptic AML1-ETO and CBFβ-MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukemia. Br J Hematol 2000, 111:1051-1056
8. Mitterbauer M, Laczika K, Novak M, Mitterbauer G, Hilgarth B, Pirc-Danoewinata H, Schwarzinger I, Haas OA, Fonatsch C, Lechner K, Jaeger U: High concordance of karyotype analysis and RT-PCR for CBFβ/MYH11 in unselected patients with acute myeloid leukemia: a single-center study. Am J Clin Pathol 2000, 113:406-410
9. Hackwell SM, Robinson DO, Harvey JF, Ross FM: Identification of false-positive CBFβ/MYH11 RT-PCR results. Leukemia 1999, 13:1617-1619
10. Langabeer SE, Gale RE, Walker H, Linch DC. Reported cryptic rearrangements of CBFβ-MYH11 in acute myeloid leukaemia are not due to false priming of contaminating DNA. Leukemia 2000, 14:944-5.2
11. Liu PP, Hajra A, Wijmenga C, Collins FS: Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia. Blood 1995, 85:2289-2302
12. Viswanatha DS, Chen I, Liu PP, Slovak ML, Rankin C, Head DR, Willman CL: Characterization and use of an antibody detecting the CBFβ-SMMHC fusion protein in inv(16)/t(16;16)-associated acute myeloid leukemias. Blood 1998, 91:1882-1890
13. Tobal K, Johnson PR, Saunders MJ, Harrison CJ, Liu Yin JA: Detection of CBFβ/MYH11 transcripts in patients with inversion and other abnormalities of chromosome 16 at presentation and remission. Br J Hematol 1995, 91:104-108
14. Dierlamm J, Stul M, Vranckx H, Michaux L, Weghuis DE, Speleman F, Selleslag D, Kramer MH, Noens LA, Cassiman JJ, Van den Berghe H, Hagemeijer A: FISH identifies inv(16)(p13q22) masked by translocations in three cases of acute myeloid leukemia. Genes Chromosomes Cancer 1998, 22:87-94
15. Pirc-Danoewinata H, Dauwerse HG, Konig M, Chudoba I, Mitterbauer M, Jager U, Breuning MH, Haas OA: CBFB/MYH11 fusion in a patient with AML-M4Eo and cytogenetically normal chromosome 16. Genes Chromosomes Cancer 2000, 29:186-191
16. Hernandez JM, Gonzalez MB, Granada I, Gutierrez N, Chillon C, Ramos F, Ribera JM, Gonzalez M, Feliu E, San Miguel J: Detection of inv(16) and t(16;16) by fluorescence in situ hybridization in acute myeloid leukemia M4Eo. Hematologica 2000, 85:481-485
17. Martinez-Climent JA, Comes AM, Vizcarra E, Reshmi S, Benet I, Marugan I, Tormo M, Terol MJ, Solano C, Arbona C, Prosper F, Barragan E, Bolufer P, Rowley JD, Garcia-Conde J: Variant three-way translocation of inversion 16 in AML-M4Eo confirmed by fluorescence in situ hybridization analysis. Cancer Genet Cytogenet 1999, 110: 111-114